Heart Protein Misfolding: Unraveling the Mystery
The del Monte Lab at the Medical University of South Carolina (MUSC) has made a groundbreaking discovery that could revolutionize our understanding of heart disease and its connection to Alzheimer's. In a recent study published in the Journal of Molecular and Cellular Cardiology, researchers identified defects in the protein repair system, specifically post-translational modifications (PTMs), which play a crucial role in maintaining heart health.
The lab's findings reveal that these PTMs are altered in patients with idiopathic dilated cardiomyopathy (IDCM), a heart condition often detected only when patients are already in advanced heart failure. By studying the three major branches of the repair system, the team uncovered changes in key PTMs that disrupt the system's ability to respond to misfolded protein stress signals. This discovery is significant because it suggests that IDCM can be viewed as a protein misfolding disease, similar to Alzheimer's.
A Multidisciplinary Approach
What makes this research particularly fascinating is the multidisciplinary approach taken by the del Monte Lab. Initially focused on the heart, the lab has expanded its scope to include the brain, bringing together cardiologists and neurologists. This shift in perspective has led to a remarkable finding: the characteristics of IDCM can be observed in the heart even before Alzheimer's is evident in the brain. As Federica del Monte, M.D., Ph.D., notes, "We may use the heart as a window to the brain."
The reverse is also true. Del Monte's work has facilitated the integration of IDCM screening into Alzheimer's clinics, emphasizing the importance of heart ultrasound in detecting the enlarged and weakened left ventricle associated with IDCM. Camilla Bacchin, M.D., a postdoctoral fellow in the lab, believes that earlier diagnosis and treatment could be within reach.
"The goal is to diagnose earlier and treat earlier to prevent the worsening of the disease," she said.
A Decade of Collaboration
The success of this research is a testament to the power of long-term collaboration. The project involved a decade-long partnership between del Monte and Marco Luciani, M.D., Ph.D., who was a postdoctoral fellow in the lab when the project began and is now a faculty member at the University of Zurich. Additionally, Luca Trocone, Ph.D., and Cristina Balla, M.D., Ph.D., both former postdoctoral fellows, have since become junior faculty members at Brigham and Women's Hospital in Boston and the University of Ferrara in Italy, respectively.
Del Monte and Bacchin highlighted the invaluable contributions of these former lab members, whose efforts have advanced the research over the years. "Their contribution doesn't vanish when they leave the nest," del Monte emphasized.
PTMs and Protein Repair
The study's focus on PTMs is particularly intriguing. Del Monte explains that the abundance of proteins is not the primary concern; rather, it's the abnormal changes that activate these proteins. Bacchin points out that the PTMs observed in disease primarily cause a shift toward cell death, leading to the self-destruction of heart cells. Age and an Alzheimer's gene were found to exacerbate this effect.
From Bench to Bedside
Looking ahead, del Monte emphasizes the need to study the entire protein repair system, including PTMs, in detail. This comprehensive approach may unlock new treatment possibilities, as similar research is already being conducted in cancer studies. Bacchin is eager to see the results of bench studies translated into clinical trials, with a focus on identifying early biomarkers of disease.
As the connection between Alzheimer's disease and heart failure becomes clearer, the potential for shared diagnosis and treatment emerges. Interdisciplinary collaborations are flourishing as the del Monte lab collaborates with cardiology, neurology, and nuclear medicine, among other disciplines. With the heart-brain connection becoming more apparent, researchers are optimistic about the prospects for earlier diagnoses and innovative therapies for both diseases.
In conclusion, this research opens up exciting avenues for further exploration, offering a deeper understanding of heart protein misfolding and its implications for both IDCM and Alzheimer's disease.
